<SEC-DOCUMENT>0001104659-19-064785.txt : 20191115
<SEC-HEADER>0001104659-19-064785.hdr.sgml : 20191115
<ACCEPTANCE-DATETIME>20191115170131
ACCESSION NUMBER:		0001104659-19-064785
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20191115
DATE AS OF CHANGE:		20191115
EFFECTIVENESS DATE:		20191115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protalix BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001006281
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				650643773
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33357
		FILM NUMBER:		191225232

	BUSINESS ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100
		BUSINESS PHONE:		972-4-988-9488

	MAIL ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHODONTIX INC
		DATE OF NAME CHANGE:	19980422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EMBASSY ACQUISITION CORP
		DATE OF NAME CHANGE:	19960124
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm1922907d2_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)
of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Filed by the Registrant&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Filed by a Party other than
the Registrant&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Protalix BioTherapeutics, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-top: Black 1pt solid"><B>(Name of Registrant as Specified In
Its Charter)</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Person(s) Filing Proxy Statement,
if other than the Registrant) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Payment of Filing Fee (Check
the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class of securities to which transaction applies: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate number of securities to which transaction applies: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed maximum aggregate value of transaction: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total fee paid: </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with preliminary materials. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.&nbsp;&nbsp;Identify the previous filing by registration statement number, or the form or schedule and the date of its filing: </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount Previously Paid: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form, Schedule or Registration Statement No: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Party: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date Filed: </FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 99%; padding: 0; font-size: 10pt; text-indent: 0"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 83px; width: 226px"></TD>
    <TD STYLE="width: 1%; padding: 0; text-indent: 0; white-space: nowrap">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">200 Broadacres Drive, 3rd Floor</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bloomfield, NJ 07003</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">P: 973.873.7700</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">F: 973.338.1430</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>www.allianceadvisors.com</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 14th, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Urgent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Your Investment in Protalix Biotherapeutics Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Stockholder,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By now you should have received your proxy materials regarding
your investment with Protalix BioTherapeutics and the upcoming Special Meeting of Stockholders which is scheduled to be held on
December 9, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of the date of this letter our records indicate your vote
has not yet been received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to have your shares represented at the upcoming meeting
you can call toll-free now at 833-785-6488 and speak with a live agent who will be able to assist you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please note you will need your unique control number which is
located on the enclosed proxy card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Alliance Advisors has been retained by Protalix Biotherapeutics
to contact you regarding this matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 54px; width: 281px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Melissa Carlson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vice President</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0083BE"><FONT STYLE="color: Black">The
Shareholder Communication Strategists</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0083BE"><FONT STYLE="color: Black">Copyright
 &copy; 2019 by Alliance Advisors, LLC. ALL RIGHTS RESERVED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #0083BE"><FONT STYLE="color: Black">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !3 .(# 2(  A$! Q$!_\0
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MI>R&)7DN"A5@K.<@*>,+Z]:QD^(2O-' -/;[0VI&R*>:.(M^WSNG3) QZ]Z
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M2:]F@$DEQ,!\Q1/NA0>,^N<#BH_"?BS7[+QU-X3\520W,S(9+:ZC0+OP-W8
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ME;\UVM^%=GX(UG^VO"]K,[;IXAY,O^\O?\1@_C7&^%&'A_Q1JWAR[^:WG!V
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M%O'#/?NURX50" QRJ_@N/QS5#Q+H%U?:[8W5EPDZ-9WQ'_/ _-_0C_@5=2H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  V 1D# 2(  A$! Q$!_\0
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M*-/TRUTN Q6<00,=S,269SZLQY)]S5NB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *J:?8+81S*',C33O,S$=V.<?@,#\*** +=%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
*444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
